The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hospital Injectable Drugs Market Research Report 2025
Synopsis
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
The global Hospital Injectable Drugs market was valued at US$ 40410 million in 2023 and is anticipated to reach US$ 56330 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs.
Report Scope
The Hospital Injectable Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Injectable Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Segment by Type
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Segment by Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
The global Hospital Injectable Drugs market was valued at US$ 40410 million in 2023 and is anticipated to reach US$ 56330 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs.
Report Scope
The Hospital Injectable Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Injectable Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Segment by Type
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Segment by Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Generic Sterile Injectables
1.2.3 Sterile Intravenous (IV) Solutions
1.3 Market by Application
1.3.1 Global Hospital Injectable Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Injectable Drugs Market Perspective (2019-2030)
2.2 Hospital Injectable Drugs Growth Trends by Region
2.2.1 Global Hospital Injectable Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital Injectable Drugs Historic Market Size by Region (2019-2024)
2.2.3 Hospital Injectable Drugs Forecasted Market Size by Region (2025-2030)
2.3 Hospital Injectable Drugs Market Dynamics
2.3.1 Hospital Injectable Drugs Industry Trends
2.3.2 Hospital Injectable Drugs Market Drivers
2.3.3 Hospital Injectable Drugs Market Challenges
2.3.4 Hospital Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Injectable Drugs Players by Revenue
3.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2019-2024)
3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue
3.4 Global Hospital Injectable Drugs Market Concentration Ratio
3.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2023
3.5 Hospital Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Hospital Injectable Drugs Product Solution and Service
3.7 Date of Enter into Hospital Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Injectable Drugs Breakdown Data by Type
4.1 Global Hospital Injectable Drugs Historic Market Size by Type (2019-2024)
4.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2025-2030)
5 Hospital Injectable Drugs Breakdown Data by Application
5.1 Global Hospital Injectable Drugs Historic Market Size by Application (2019-2024)
5.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital Injectable Drugs Market Size (2019-2030)
6.2 North America Hospital Injectable Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital Injectable Drugs Market Size by Country (2019-2024)
6.4 North America Hospital Injectable Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Injectable Drugs Market Size (2019-2030)
7.2 Europe Hospital Injectable Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital Injectable Drugs Market Size by Country (2019-2024)
7.4 Europe Hospital Injectable Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Injectable Drugs Market Size (2019-2030)
8.2 Asia-Pacific Hospital Injectable Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Injectable Drugs Market Size (2019-2030)
9.2 Latin America Hospital Injectable Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital Injectable Drugs Market Size by Country (2019-2024)
9.4 Latin America Hospital Injectable Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Injectable Drugs Market Size (2019-2030)
10.2 Middle East & Africa Hospital Injectable Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Detail
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2019-2024)
11.1.5 Hospira (Pfizer Inc.) Recent Development
11.2 Baxter
11.2.1 Baxter Company Detail
11.2.2 Baxter Business Overview
11.2.3 Baxter Hospital Injectable Drugs Introduction
11.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2019-2024)
11.2.5 Baxter Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction
11.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2019-2024)
11.3.5 Fresenius Kabi Recent Development
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Detail
11.4.2 Sandoz (Novartis) Business Overview
11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction
11.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2019-2024)
11.4.5 Sandoz (Novartis) Recent Development
11.5 Hikma Pharmaceuticals PLC
11.5.1 Hikma Pharmaceuticals PLC Company Detail
11.5.2 Hikma Pharmaceuticals PLC Business Overview
11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction
11.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2019-2024)
11.5.5 Hikma Pharmaceuticals PLC Recent Development
11.6 Dr. Reddy’s Laboratories Ltd
11.6.1 Dr. Reddy’s Laboratories Ltd Company Detail
11.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Introduction
11.6.4 Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2019-2024)
11.6.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.7 Grifols
11.7.1 Grifols Company Detail
11.7.2 Grifols Business Overview
11.7.3 Grifols Hospital Injectable Drugs Introduction
11.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2019-2024)
11.7.5 Grifols Recent Development
11.8 Nichi-Iko Group (Sagent)
11.8.1 Nichi-Iko Group (Sagent) Company Detail
11.8.2 Nichi-Iko Group (Sagent) Business Overview
11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction
11.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2019-2024)
11.8.5 Nichi-Iko Group (Sagent) Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Detail
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction
11.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Otsuka
11.10.1 Otsuka Company Detail
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Hospital Injectable Drugs Introduction
11.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2019-2024)
11.10.5 Otsuka Recent Development
11.11 B.Braun
11.11.1 B.Braun Company Detail
11.11.2 B.Braun Business Overview
11.11.3 B.Braun Hospital Injectable Drugs Introduction
11.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2019-2024)
11.11.5 B.Braun Recent Development
11.12 JW Life Science
11.12.1 JW Life Science Company Detail
11.12.2 JW Life Science Business Overview
11.12.3 JW Life Science Hospital Injectable Drugs Introduction
11.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2019-2024)
11.12.5 JW Life Science Recent Development
11.13 Auromedics
11.13.1 Auromedics Company Detail
11.13.2 Auromedics Business Overview
11.13.3 Auromedics Hospital Injectable Drugs Introduction
11.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2019-2024)
11.13.5 Auromedics Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Hospital Injectable Drugs Introduction
11.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2019-2024)
11.14.5 Sanofi Recent Development
11.15 Gland Pharma
11.15.1 Gland Pharma Company Detail
11.15.2 Gland Pharma Business Overview
11.15.3 Gland Pharma Hospital Injectable Drugs Introduction
11.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2019-2024)
11.15.5 Gland Pharma Recent Development
11.16 Endo International PLC
11.16.1 Endo International PLC Company Detail
11.16.2 Endo International PLC Business Overview
11.16.3 Endo International PLC Hospital Injectable Drugs Introduction
11.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2019-2024)
11.16.5 Endo International PLC Recent Development
11.17 Sichuan Kelun Pharmaceutical
11.17.1 Sichuan Kelun Pharmaceutical Company Detail
11.17.2 Sichuan Kelun Pharmaceutical Business Overview
11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction
11.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024)
11.17.5 Sichuan Kelun Pharmaceutical Recent Development
11.18 Cisen Pharmaceutical
11.18.1 Cisen Pharmaceutical Company Detail
11.18.2 Cisen Pharmaceutical Business Overview
11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction
11.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024)
11.18.5 Cisen Pharmaceutical Recent Development
11.19 Shijiazhuang No. 4 Pharmaceutical
11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Detail
11.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction
11.19.4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024)
11.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Development
11.20 Shandong Hualu Pharmaceutical
11.20.1 Shandong Hualu Pharmaceutical Company Detail
11.20.2 Shandong Hualu Pharmaceutical Business Overview
11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction
11.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024)
11.20.5 Shandong Hualu Pharmaceutical Recent Development
11.21 CR Double-Crane
11.21.1 CR Double-Crane Company Detail
11.21.2 CR Double-Crane Business Overview
11.21.3 CR Double-Crane Hospital Injectable Drugs Introduction
11.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2019-2024)
11.21.5 CR Double-Crane Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Generic Sterile Injectables
Table 3. Key Players of Sterile Intravenous (IV) Solutions
Table 4. Global Hospital Injectable Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Hospital Injectable Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hospital Injectable Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Hospital Injectable Drugs Market Share by Region (2019-2024)
Table 8. Global Hospital Injectable Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Hospital Injectable Drugs Market Share by Region (2025-2030)
Table 10. Hospital Injectable Drugs Market Trends
Table 11. Hospital Injectable Drugs Market Drivers
Table 12. Hospital Injectable Drugs Market Challenges
Table 13. Hospital Injectable Drugs Market Restraints
Table 14. Global Hospital Injectable Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Hospital Injectable Drugs Market Share by Players (2019-2024)
Table 16. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2023)
Table 17. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hospital Injectable Drugs Product Solution and Service
Table 21. Date of Enter into Hospital Injectable Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital Injectable Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Hospital Injectable Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Hospital Injectable Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Hospital Injectable Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Hospital Injectable Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Hospital Injectable Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Hospital Injectable Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Hospital Injectable Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Hospital Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Hospital Injectable Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Hospital Injectable Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Hospital Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Hospital Injectable Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Hospital Injectable Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Hospital Injectable Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hospital Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Hospital Injectable Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Hospital Injectable Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Hospital Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Hospira (Pfizer Inc.) Company Detail
Table 47. Hospira (Pfizer Inc.) Business Overview
Table 48. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 49. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 50. Hospira (Pfizer Inc.) Recent Development
Table 51. Baxter Company Detail
Table 52. Baxter Business Overview
Table 53. Baxter Hospital Injectable Drugs Product
Table 54. Baxter Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 55. Baxter Recent Development
Table 56. Fresenius Kabi Company Detail
Table 57. Fresenius Kabi Business Overview
Table 58. Fresenius Kabi Hospital Injectable Drugs Product
Table 59. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 60. Fresenius Kabi Recent Development
Table 61. Sandoz (Novartis) Company Detail
Table 62. Sandoz (Novartis) Business Overview
Table 63. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 64. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 65. Sandoz (Novartis) Recent Development
Table 66. Hikma Pharmaceuticals PLC Company Detail
Table 67. Hikma Pharmaceuticals PLC Business Overview
Table 68. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 69. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 70. Hikma Pharmaceuticals PLC Recent Development
Table 71. Dr. Reddy’s Laboratories Ltd Company Detail
Table 72. Dr. Reddy’s Laboratories Ltd Business Overview
Table 73. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
Table 74. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 75. Dr. Reddy’s Laboratories Ltd Recent Development
Table 76. Grifols Company Detail
Table 77. Grifols Business Overview
Table 78. Grifols Hospital Injectable Drugs Product
Table 79. Grifols Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 80. Grifols Recent Development
Table 81. Nichi-Iko Group (Sagent) Company Detail
Table 82. Nichi-Iko Group (Sagent) Business Overview
Table 83. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
Table 84. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 85. Nichi-Iko Group (Sagent) Recent Development
Table 86. Teva Pharmaceutical Company Detail
Table 87. Teva Pharmaceutical Business Overview
Table 88. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 89. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 90. Teva Pharmaceutical Recent Development
Table 91. Otsuka Company Detail
Table 92. Otsuka Business Overview
Table 93. Otsuka Hospital Injectable Drugs Product
Table 94. Otsuka Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 95. Otsuka Recent Development
Table 96. B.Braun Company Detail
Table 97. B.Braun Business Overview
Table 98. B.Braun Hospital Injectable Drugs Product
Table 99. B.Braun Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 100. B.Braun Recent Development
Table 101. JW Life Science Company Detail
Table 102. JW Life Science Business Overview
Table 103. JW Life Science Hospital Injectable Drugs Product
Table 104. JW Life Science Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 105. JW Life Science Recent Development
Table 106. Auromedics Company Detail
Table 107. Auromedics Business Overview
Table 108. Auromedics Hospital Injectable Drugs Product
Table 109. Auromedics Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 110. Auromedics Recent Development
Table 111. Sanofi Company Detail
Table 112. Sanofi Business Overview
Table 113. Sanofi Hospital Injectable Drugs Product
Table 114. Sanofi Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Gland Pharma Company Detail
Table 117. Gland Pharma Business Overview
Table 118. Gland Pharma Hospital Injectable Drugs Product
Table 119. Gland Pharma Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 120. Gland Pharma Recent Development
Table 121. Endo International PLC Company Detail
Table 122. Endo International PLC Business Overview
Table 123. Endo International PLC Hospital Injectable Drugs Product
Table 124. Endo International PLC Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 125. Endo International PLC Recent Development
Table 126. Sichuan Kelun Pharmaceutical Company Detail
Table 127. Sichuan Kelun Pharmaceutical Business Overview
Table 128. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
Table 129. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 130. Sichuan Kelun Pharmaceutical Recent Development
Table 131. Cisen Pharmaceutical Company Detail
Table 132. Cisen Pharmaceutical Business Overview
Table 133. Cisen Pharmaceutical Hospital Injectable Drugs Product
Table 134. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 135. Cisen Pharmaceutical Recent Development
Table 136. Shijiazhuang No. 4 Pharmaceutical Company Detail
Table 137. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 138. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
Table 139. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 140. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 141. Shandong Hualu Pharmaceutical Company Detail
Table 142. Shandong Hualu Pharmaceutical Business Overview
Table 143. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
Table 144. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 145. Shandong Hualu Pharmaceutical Recent Development
Table 146. CR Double-Crane Company Detail
Table 147. CR Double-Crane Business Overview
Table 148. CR Double-Crane Hospital Injectable Drugs Product
Table 149. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2019-2024) & (US$ Million)
Table 150. CR Double-Crane Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Injectable Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital Injectable Drugs Market Share by Type: 2023 VS 2030
Figure 3. Generic Sterile Injectables Features
Figure 4. Sterile Intravenous (IV) Solutions Features
Figure 5. Global Hospital Injectable Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Hospital Injectable Drugs Market Share by Application: 2023 VS 2030
Figure 7. Oncology Case Studies
Figure 8. Anesthesia Case Studies
Figure 9. Anti-Infectives Case Studies
Figure 10. Parenteral Nutrition Case Studies
Figure 11. Cardiovascular Diseases Case Studies
Figure 12. Hospital Injectable Drugs Report Years Considered
Figure 13. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Hospital Injectable Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hospital Injectable Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Hospital Injectable Drugs Market Share by Players in 2023
Figure 17. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2023
Figure 19. North America Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Hospital Injectable Drugs Market Share by Country (2019-2030)
Figure 21. United States Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hospital Injectable Drugs Market Share by Country (2019-2030)
Figure 25. Germany Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital Injectable Drugs Market Share by Region (2019-2030)
Figure 33. China Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hospital Injectable Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 48. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 49. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 50. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 51. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 52. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 53. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 54. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 56. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 57. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 58. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 59. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 60. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 61. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 62. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 63. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 64. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 65. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 66. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 67. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
